14 results
425
EX-2.1
LAB
Standard BioTools Inc.
4 Oct 23
Business combination disclosure
8:13am
the FCPA, as amended, any rules or regulations thereunder, or any other applicable United States or foreign anti-corruption or anti-bribery laws
8-K
EX-2.1
LAB
Standard BioTools Inc.
4 Oct 23
Standard BioTools and SomaLogic to Combine in All-Stock Merger
8:08am
the FCPA, as amended, any rules or regulations thereunder, or any other applicable United States or foreign anti-corruption or anti-bribery laws
PRE 14A
bgqmd398hbnzz
11 Feb 22
Preliminary proxy
9:31pm
DEFA14A
8mm9vsf5x26pm0k0 ih
24 Jan 22
Additional proxy soliciting materials
5:27pm
8-K
EX-10.3
h90geal7hxwc7
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-10.4
uop1g4sb
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-1.1
55fsr cm4
4 Mar 20
Entry into a Material Definitive Agreement
9:41pm
8-K
EX-10.1
uwwgasn5au6
22 Nov 19
Fluidigm Corporation Announces Proposed Private Offering of $45 Million of Convertible Senior Notes
4:26pm
- Prev
- 1
- Next